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Abstract 
Thalassaemia, triggered by defects in the globin genes, is one of the most common monogenic 
diseases. The -thalassaemia carrier state is clinically asymptomatic, thus, making it onerous to 
diagnose. The current gold standard technique is implausible to be used for onsite carrier 
detection as the method necessitates expensive instruments, skilled manpower and time. In this 
study, we have tried to classify the carriers from the healthy samples based on their blood droplet 
drying patterns using image analysis based tools and subsequently develop an in-house program 
for automated classification of the same. This automatic, rapid, less laborious and cost-effective 
technique will significantly increase the total number of carriers that are screened for 
thalassaemia per year in the country, thus, reducing the burden in the state run advanced health 
facilities. 
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1. Introduction 
Thalassaemia is one of the most common single gene disorders in which the normal production 
of haemoglobin is impaired. This autosomal recessive disorder decreases the synthesis of either 
the - globin or - globin chains that compose adult haemoglobin, HbA (22)1, thus causing 
imbalance in the globin chain synthesis. This syndrome is mostly prevalent in the Mediterranean, 
Middle East, tropical Africa, Indian subcontinent and Central Asia, and in aggregate is among 
the most common inherited disorders of humans. Indian populations account to ~10% of the 
world’s thalassaemia carriers.  
- thalassaemia is caused by the inadequate synthesis (+) or absence (0) of the  globin chains2 
whereas deficient synthesis of  chains leads to  thalassaemia.3  The hematological 
consequences of reduced synthesis of one globin chain results from haemoglobin deficiency and 
also from a relative excess of the other globin chain, especially in -thalassaemia. The -
thalassaemia carrier state is clinically asymptomatic and thus largely remains undiagnosed. The 
major challenge in approaching ‘zero-thalassaemia’ nation is to screen the entire population 
under the reproductive age group. The gold standard method that is used for carrier detection in 
hospitals, at present, is High Performance Liquid Chromatography (HPLC) which is a laboratory 
based method requiring expensive instruments, skilled manpower and time, thus, making it 
difficult to be used as an onsite method.  Also, Nestroft4 can be used in some cases for detection 
of -thalassaemia carriers. The inaccurate eye estimation, long standing hours and higher 
percentage of false negative results, however, made this technique inapposite for onsite detection 
of carriers. A rapid, portable and automated technology for thalassaemia carrier screening is 
hence of significant importance. 
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Detection of diseases from drying pattern of body fluids has recently been emerging as a tool for 
automated and rapid diagnosis of several diseases.5,6,7 Whole blood, a complex colloidal 
suspension, behaves like a non-Newtonian fluid 8 and leads to the formation of several interesting 
and complex patterns when dried on a solid substrate. Numerous intra-cellular and 
macromolecular interactions in the drying droplets of blood or plasma stem up the final 
morphologies of the resulting dried patterns. The onset of any pathological abnormality alters the 
cellular and the macromolecular components of the blood, thus altering their drying patterns. 
This technique can hence be used as a simple diagnostic tool for the detection of several diseases 
based on the dried drop patterns of the healthy and the diseased subjects.  
Specific diseases give rise to distinct drying patterns where the final patterns depend on several 
factors such as plasma content and the morphology of red blood cells. This technique was first 
developed in Russia with the ‘Litos’ test system9 where urine samples of patients suffering from 
kidney stones were found to leave a distinct drying pattern.5, 10 The efficacy of droplet drying of 
body fluids has also been studied for the detection of various diseases like hepatitis, breast 
cancer, leukemia, lung cancer, pathogen infection, premature delivery and kidney diseases.5,7,11,12 
Recently the potency of the technique to diagnose diseases based on the whole blood drop drying 
patterns was extensively investigated by Brutin et al.11 where it was found that the dried patterns 
of a drop of blood from a healthy subject was markedly different from that of a patient suffering 
from anaemia and hyperlipidaemia. Yakhno et al. carried out several investigations 9,10,12,13 
studying the effect of various factors influencing the drying pattern of biological fluids. In one of 
his recent investigations, patterns observed by drying droplets of biological fluids from cattle 
were used for the detection of leukemia and tuberculosis14.   
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There is an urgent need in the developing countries to revolutionize the healthcare industry with 
simple, cost effective and non-invasive techniques for disease diagnosis. In this aspect, several 
researchers have come up with many innovative lab-on-chip devices where a portable paper 
based device or a smartphone can rapidly detect the serum cholesterol, perform genetic testing 
and can detect malaria even in limited resource settings.15-18 With the recent advancements in the 
field of microfluidics, a simple point of care device can now diagnose and monitor jaundice, 
detect analytes in blood and can even identify sickle cell disease based on the density differences 
of the red blood cells 19-21 . Till date no attempt has been made to detect the thalassaemia carriers 
by exploiting the blood droplet drying technique which being both rapid & less laborious can 
potentially aid in the screening of the carrier samples of the entire population under reproductive 
age. In this study, the aim is to separate the thalassaemia carriers from the healthy subjects based 
on the blood droplet drying patterns using image analysis based tools to identify the distinct 
signatory features in the patterns of the respective samples. The proposed technique can be 
instrumental in developing a rapid, less laborious and cost effective ‘on-field’ screening method 
which will enable the initial screening of carriers from the large population. 
2. MATERIALS AND METHODS 
2.1 Sample Collection: Thalassaemia carrier samples were collected from the individuals, 
family members of the thalassaemia patients visiting Institute of Haematology and Transfusion 
medicine (IHTM), Medical College, Kolkata for thalassaemia screening and also from outreach 
camps, conducted by IHTM routinely. The study population consisted of a total of 100 carrier 
and healthy samples. Healthy samples were also collected from the camps conducted by IHTM. 
Informed consent and clinical history of the samples were recorded. Thorough clinical 
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examinations for pallor, jaundice, and splenomegaly were done. 2ml of blood samples were 
collected in EDTA coated vials from the peripheral veins of individuals. 
The individuals (non-smokers, age within 20 to 40 yrs, body weight 50±20 kg, resting heart rate 
being 73±4 beats/minute, systolic pressure-120.5±7 mm Hg and diastolic pressure being 84±3 
mm Hg, devoid of any known disease & disorders) with normal ferritin value (> 30 ng/L) and 
detecting beta/HbE trait by HPLC analysis (HbA2 value 4.5 – 7.5, HbA2E value 20.0 – 30.0) 
were included in the group of carriers.  
The individuals (non-smokers, age within 20 to 40 yrs, body weight 50±20 kg, resting heart rate 
being 73±4 beats/minute, systolic pressure-120.5±7 mm Hg and diastolic pressure being 84±3 
mm Hg, devoid of any known disease & disorders) with normal HPLC parameters,  ferritin value 
(> 30 ng/L), and normal RBC indices were considered as healthy. 
2.2 Haematological Analysis: Complete hemogram was performed on Sysmex (KX- 21) 
automated cell counter. Haemoglobin analysis was estimated by high performance liquid 
chromatography (HPLC, from Bio Rad Variant II) and Feritin level was measured by ELISA 
based method. The Mean Corpuscular Haemoglobin (MCH) and the Mean Corpuscular Volume 
(MCV) of the healthy and the carrier samples have been reported in Table 1. 
2.3 Sample Characterization: The pertinent physiochemical properties of the blood samples 
were evaluated. The first of these was the estimation of the surface tension by placing sessile 
droplets (2 µL) of both the healthy and carrier samples on cleaned glass substrates by using a 
Goniometer (250 G1, Ram’ehart, Germany). The numerical values of the surface tension are 
reported in Table I. The zeta potentials of the samples were evaluated (Malvern Instruments, 
Model: ZEN 3600) and were found to be negatively charged with the order of the surface 
potential (𝜙, mV) being  𝜙Healthy >𝜙Carrier. 
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Table 1: Characterization of the samples 
Sample Type Surface Tension 
(mN/m) 
Zeta Potential 
(mV) 
MCV 
(fl) 
MCH 
(pg) 
Healthy 52 -12 90 30 
Carrier 51 -9 70 24 
 
 
 
 
2.4 Substrate preparation for droplet drying:  
Glass slides (Material Composition: SiO2 - 81%, B2O3 - 13%, Na2O + K2O – 4%, Al2O3 – 2%) 
procured from HiMedia Laboratories Pvt. Ltd. have been used as substrates. They were 
subjected to a thorough cleaning protocol that comprised of ultrasonication with acetone, 
followed by de-ionized water (10 minutes each). These cleaned slides were dried in a hot air 
oven at 95ºC to ensure complete removal of the surface moisture.
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2.5 Droplet drying & Imaging: Sessile droplets (whole blood of both healthy and carrier 
samples) of 2 μl volume were allowed to dry on the cleaned glass substrates. The final dried 
patterns were then observed under the optical microscope (LEICA DMi8 A) in transmission 
mode with 5x magnification. All the experiments were performed at room temperature (~ 25ºC) 
and within 72 hours of the sample collection. The high quality images were analyzed in ImageJ 
software (v: 1.47 platform) to evaluate the average crack lengths of the dried blood drops. 
3. RESULTS 
3.1 Droplet Drying Patters Of Whole Blood on Glass substrates 
Whole blood droplets of 2μl volume were allowed to dry naturally at room temperature with 
controlled humidity on the cleaned glass substrates. To check the reproducibility of the observed 
patterns, 6 drops of each blood sample were dried and analysed in each set. The average time 
required for the drops to dry on the glass slides was around 20-25 minutes. The study population 
consisted of 100 samples consisting of both healthy and carrier samples.  It was observed that the 
radial cracks in the drying patterns of the healthy blood samples were significantly longer as 
compared to those in the carriers (Figures 1-4). The area of the central core was distinctly more 
in the carrier samples where more branching from the parent cracks were observed as compared 
to the patterns obtained from the healthy samples.  
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Figure 1: Dried blood drop patterns of carrier samples (the numbers on the top left denote the serial numbers 
whereas the ones below denote the average crack lengths) 
(The dried drop blood patterns of the remaining carrier samples have been shown in Figure S1 of the ESI) 
 
 
Figure 2: Dried blood drop patterns of carrier samples (the numbers on the top left denote the serial numbers and the 
ones below denote the average crack lengths) 
(The dried drop blood patterns of the remaining carrier samples have been shown in Figure S1 of the ESI) 
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Figure 3: Dried blood drop patterns of healthy samples (the numbers on the top left denote the serial numbers and 
the ones below denote the average crack lengths) 
(The dried drop blood patterns of the remaining carrier samples have been shown in Figure S2 of the ESI) 
 
Figure 4: Dried blood drop patterns of healthy samples (the numbers on the top left denote the serial numbers and 
the ones below denote the average crack lengths) 
(The dried drop blood patterns of the remaining carrier samples have been shown in Figure S2 of the ESI) 
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In order to ascertain the accuracy of this detection method based on the image analysis 
technique, further validation was done by comparing the results with the with the gold standard 
methods, as performed by clinicians at IHTM and have been produced below in Tables 2 and 3. 
Table 2: Classification of carrier samples by both analyzing the crack lengths and the clinical diagnostic method 
(The analysis of the remaining carrier samples have been shown in table S3 of the ESI) 
SL.No Age Sex Diagnosis HPLC 
Test 
No. 
HB MCV MCH HBA0 HBA2 HBF HBA2e Crack 
length 
(in 
microns) 
1 24 Male HbE carrier 922 13.5 82.8 24.5 63  1.1 26.3 677 
2 27 Female Beta 
thalassaemia 
carrier 
937 11.1 83.2 25.2 80.5 5.3 2.5  727 
3 29 Male Beta 
thalassaemia 
carrier 
954 11.1 61.9 17.8 84.6 5.4 0.8  682 
4 32 Male HbE carrier 966 14.1 89.1 28 63.1  0.7 27.8 609 
5 26 Female HbE carrier 974 10.8 87 26.5 64.1  1.3 26.6 683 
6 22 Female HbE carrier 983 11.7 81.5 24.3 65.3  0.7 26.1 608 
7 36 Male Beta 
thalassaemia 
carrier 
989 14.3 82.2 24.9 84.9 5.1 0.3  631 
8 25 Female HbE carrier 996 9.4 90.4 27.2 67.3  1 25.6 598 
9 28 Female HbE carrier 1017 10.1 76.3 25.4 64.4  0.4 27.3 618 
10 25 Male Beta 
thalassaemia 
carrier 
1018 12 63.1 19.7 83.3 5.8 0.3  701 
11 38 Male HbE carrier 1035 15 82.4 27.2 67.5  0.4 26.4 688 
12 24 Female HbE carrier 1038 9 79.4 25.7 65.3  0.5 26.2 635 
13 23 Male HbE carrier 1048 14 75.1 23.5 66  0.4 25.5 643 
14 26 Female Beta 
thalassaemia 
carrier 
1053 9.3 65.6 20.5 86.3 4.5 1.1  523 
15 38 Male Beta 
thalassaemia 
carrier 
1054 12 66.8 20.8 84.8 4.7 1.3  675 
16 24 Female Beta 
thalassaemia 
carrier 
1055 9.4 70.1 22.3 85.5 5.6 0.9  511 
17 19 Female HbE carrier 1061 13 69.1 23.1 63.6  0.6 28.3 627 
18 20 Female HbE carrier 1091 10 77.1 25.7 65  0.9 26.3 505 
19 25 Female HbE carrier 1093 11 74.2 24.3 63.3  1.1 28.5 601 
20 20 Female HbE carrier 303 10.9 76.4 24.3 64.3  1.8 26 723 
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Table 3: Classification of normal samples by both analyzing the crack lengths and the clinical diagnostic method 
(The analysis of the remaining carrier samples have been shown in table S4 of the ESI) 
Sl .No Sex HPLC Test 
NO. 
HB MCV MCH HBA2 HBF Crack 
Length (in 
microns) 
21 Male 71 14 81.4 25.7 3.2 0.2 916 
 
22 Female 62 10 63.7 18.6 2.7 0.2 975 
 
23 Male 34 13 97 30.7 3.4 0.2 840 
 
24 Female 5 9.7 82.1 23.5 2.6 0.6 1032 
25 Female 95 9.8 71.9 21.7 2.6 0.3 877 
 
26 Male 83 13 68 20.7 3.5 3.1 883 
 
27 Male 91 11 69.8 21.4 2.9 0.2 1013 
 
28 Female 20 11 73.4 21.7 2.7 0.2 881 
29 Female 96 11 69.3 20.5 3.2 0.2 863 
 
30 Female 69 13 80 24 3 0.2 893 
 
31 Female 37 9.7 76.3 22.8 3.4 0.3 861 
32 Female 14 10.3 74.5 21.9 2.5 0.3 883 
33 Female 81 11 72.2 22.2 3 0.2 870 
 
34 Male 75 14 74.4 22.8 3.2 0.1 847 
 
35 Male 59 12 82.6 25.3 2.8 0.2 911 
 
36 Female 6 10 66.9 19.7 2.5 0.1 814 
 
37 Female 94 11 75.8 22.3 3.3 0.2 861 
 
38 Male 2 13.2 72.4 21.2 2.3 0.2 1397 
39 Female 67 10 72.1 22.4 2.9 0.3 942 
 
40 Male 51 14 84.5 26.3 3.2 0.3 916 
 
 
Increasing the droplet volume to 4 μl prompted a proportional increase in the lengths of the 
radial cracks in both the carrier and the healthy samples (as shown in the figure S5 of the ESI). 
However, the droplet volume was optimized to 2 μl, as droplets of larger volumes subjected the 
crack lengths to human bias, owing to its difficulty in dispensing a perfectly circular droplet on 
the glass slides. 
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3.2 Determining the Threshold Crack Length for Classification of Samples 
To determine the threshold crack length below which the samples can be classified as carriers, 
99% confidence interval for the population of 100 samples was calculated using the following 
equation: 
Lower limit: 2.576x
n

−  , Upper Limit: 2.576x
n

+ …………(1) 
Where, x = average crack length of the healthy/carrier samples in microns,  = standard 
deviation and n= number of samples. 
Table 4: Estimation of parameters for 99% confidence interval 
Sample x    n  Lower Limit Upper Limit 
Healthy 936.313 111.582 50 895.664 976.962 
Carrier 652.124 69.839 50 626.681 677.566 
 
(Lower Limit) Healthy – (Upper Limit) Carrier = (895.664 – 677.566) μm = 218.098 μm  
Mean= 218.098/2 = 109.049 μm 
(Threshold Upper Limit)Carrier = (677.566+109.0195) = 786.615 μm = ~800 μm 
Figure 5 depicts the variation in the range of crack lengths as observed in the dried droplet 
patterns of the healthy and the carrier samples.  
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Figure 5: Variation in crack lengths in the dried drop patterns of the healthy and carrier samples 
The determining crack length was estimated to be 800 μm, as shown, from the confidence 
interval of both the carrier and the normal samples. A sample whose average crack length was 
less than 800 microns was classified as a carrier sample, whereas the ones with larger radial 
cracks were considered as normal. Identifying the carrier samples by this image analysis 
technique gave zero false negative results. 
3.3 Process Automation 
In order to automate the system, a Graphical User Interface (GUI) was designed (using 
MATLAB R2017a) for this purpose. We named the system ‘ASAP’, for Automated Span 
Analysis of Patterns. First, the foreground droplet was separated from the noisy background by 
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binarizing the image and detecting the longest connected boundary in the binary image. Then, 
the red hue from the image was removed after converting the colour palette to HSV. The image 
was then binarized and morphological operations of dilation22 and closure23 were applied using 
disk shaped structuring element of radii 30 and 10 pixels respectively to connect all the cracks 
whose links broke due to binarization and thresholding. A dilation was again performed on this 
image using the same structuring element as the one used for closing. This was done to avoid 
spurious skeletal branches in the thinned image. Then, the image was morphologically thinned24 
and branch points were detected by considering the 8 connected neighbours of each pixel. The 
branch points detected at the boundary of the droplet in the binary image were considered as the 
starting points of the cracks. The branch points were then erased from the image using a logical 
AND operation in a 3X3 neighbourhood of the branch point, so that each crack can be labelled as 
a component separately. Connected component labeling25 was applied to the image and the 
components containing the start of the cracks were considered, and the corresponding end point 
of the labeled component was found. The Euclidean Distance between the start and the end 
points was taken as the length of the crack, and the pixel to length scale was taken into account 
while reporting the value. Values away from the median that were at least three median absolute 
deviations away were taken to be outliers and removed. The mean of all refined crack lengths in 
the image was considered for further calculations, and the sample was categorized based on this 
value. Figure 6 shows the steps that were followed to determine the length of the radial cracks in 
the dried blood drop patterns. 
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Figure 6: Steps followed for determining the crack length using using MATLAB R2017 a 
‘ASAP’ will allow the practitioner to upload the image of the dried blood drop pattern in a 
computer in order to run the application. The picture can be browsed for and uploaded in the 
application. Once the practitioner clicks ‘Evaluate’, the cracks are identified, and the crack 
length along with an image of the detected cracks is displayed on the screen, thus, categorizing 
the sample as healthy or carrier. There is also a provision for analyzing a set of images at once 
and directly storing the images in a file instead of going through the GUI one by one for every 
image. Figure 7 shows the interface of the developed system ‘ASAP’. 
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Figure 7: User interface of the developed system ‘ASAP’ 
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Table 5 depicts the comparison between the crack lengths obtained from both, the in-house 
developed program – ASAP and the open source software ImageJ. It is to be noted that the crack 
lengths determined using ASAP, resulted in a marginal error of  10% when compared with the 
results obtained manually. 
Table 5: Comparison of the crack lengths as estimated by ImageJ and ASAP 
(The analysis of the remaining samples have been shown in table S6 of the ESI) 
SL.NO Crack length as estimated by 
ImageJ 
(m) 
Crack length as detected by 
ASAP 
(m) 
Category 
1 677 712 Carrier 
2 727 743 Carrier 
3 682 754 Carrier 
4 609 700 Carrier 
5 683 700 Carrier 
6 608 649 Carrier 
7 631 457 Carrier 
8 598 711 Carrier 
9 618 769 Carrier 
10 701 740 Carrier 
11 688 737 Carrier 
12 635 654 Carrier 
13 643 665 Carrier 
14 523 462 Carrier 
15 675 736 Carrier 
16 511 375 Carrier 
17 627 313 Carrier 
18 505 716 Carrier 
19 601 269 Carrier 
20 723 698 Carrier 
21 916 
 
914 Healthy 
22 975 
 
971 Healthy 
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23 840 
 
828 Healthy 
24 1032 1039 Healthy 
25 877 
 
868 Healthy 
26 883 
 
893 Healthy 
27 1013 
 
1000 Healthy 
28 881 895 Healthy 
29 863 
 
847 Healthy 
30 893 
 
909 Healthy 
31 861 802 Healthy 
32 883 865 Healthy 
33 870 
 
889 Healthy 
34 847 
 
825 Healthy 
35 911 
 
888 Healthy 
36 814 
 
837 Healthy 
37 861 
 
838 Healthy 
38 1397 1373 Healthy 
39 942 
 
917 Healthy 
40 916 
 
887 Healthy 
 
3.4 Role of interaction energies in determining the dried drop patterns 
The differences in the crack lengths as observed in the dried patterns patterns formed by the 
healthy and the carrier blood samples, can be attributed to the differences in the fundamental 
cellular level physical interactions i.e. the cell-substrate and the cell-cell interactions. Each of 
these interactions is majorly contributed by the repulsive double layer and the attractive van 
der Waals energies, which together comprise the DLVO interactions.  
Considering the total number of red blood cells in a 2l droplet (~8 * 106 cells), a multilayer 
stacked arrangement of red blood cells has been taken into account. The cells are assumed to 
be spherical, in volume equivalence, and arranged in a hexagonal close packing arrangement. 
To facilitate adequate analysis, we have considered the interaction energies of the state of the 
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system just before the formation of the cracks. Thus, at this state, it is reasonable to assume 
that major portion of the liquid in the droplet has evaporated, and the remaining liquid is 
present in the void spaces of the hexagonal close packing arrangement.  
The cell-substrate (CS) interactions are assumed to be limited to the bottommost layer of the 
multilayer stacked arrangement, as the DLVO interaction energies are negligible for the cells 
in layers which are not in direct contact with the substrate (in this case, glass). The cell-
substrate van der Waals interaction energy can be expressed as 26,27: 
_ ln
6 2 2
VDW CS
A a a h
U
h h a h a
    
= + +    + +    
…………. (2) 
where, A is the Hamaker constant; ℎ is the distance between the cell and substrate (as the 
charges between the cells and substrate are not diffused, ℎ can be considered to be in order of 
the Debye-Huckel length i.e. ~0.1-1nm) and a is the equivalent radius of the red blood cells. 
The cell-substrate electrical double layer interaction energy can be expressed as: 
( )2 2 21 2_ 1 22 2 2 2
1 2
2 1
2 .ln ln(1 )
1
h
hB
EDL CS h
i
n k T e
U a e
r h e




  
   
−
−
−
    +
= + − −    + −    
…………. (3) 
Where n∞ is the number of cells in the lowermost layer; r is the base diameter of the droplet; 
hi is the height of a single layer of cells ; T is the temperature; kB is the Boltzmann constant; 
 is the reciprocal of Debye-Huckel length; ℎ is the distance between the cell and substrate 
(as the charges between the cells and substrate are not diffused, ℎ can be considered to be in 
order of the Debye-Huckel length i.e. ~0.1-1nm); 𝜑1is the surface potential of cell and 𝜑2is 
the surface potential of the substrate. 
All the layers of cells in the system are subjected to cell-cell (CC) interactions. Due to 
hexagonal close packing, each cell is in contact with 12 other neighbouring cells (neglecting 
the edge effects). The cell-cell interactions are assumed to be solely limited to the cells in 
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contact because the DLVO interaction energies drop to negligible values for distances 
between cells greater than immediate contact. The cell-cell van der Waals interaction energy 
can be expressed as26: 
2
_
6 (2 )
VDW CC
A a
U
h a
 
=  
 
………. (4) 
Where, A is the Hamaker constant; h is the distance between two cells (considering the total 
length of the 55 amino acids, which are four folded, the distance can be assumed to ~10nm) 
and a is the equivalent radius of the red blood cells. The cell-cell electrical double layer 
interaction can be expressed as:  
( )2 21 2_ 2 2 2 2
1 2
2 1
12*2 .ln ln(1 ) 2 / 2
1
h
hB
EDL CC Stackh
i
k T e n
U a e N
e r h





   
−
− 
−
     +
= − − −     + −      
  .….(5)                                                                                                                                                    
Where, a is the equivalent radius of the red blood cells; h is the distance between two cells 
(considering the total length of the 55 amino acids, which are four folded, the distance can be 
assumed to ~10nm); n∞ is the number of cells in a single layer; NStack is the total number of 
stacks in the hexagonal close packed arrangement of cells; T is the temperature; kB is the 
Boltzmann constant;  is the reciprocal of Debye-Huckel length, and 𝜑1and 𝜑2are the 
surface potential of erythrocytes (𝜑1 = 𝜑2), r is the base diameter of the droplet and hi is the 
height of a single layer of cells . 
The parameters that have been used for evaluation of the aforementioned total interaction 
energy, as used in this study, are listed in Table 6.  
 
 
 
 
22 | P a g e  
 
Table 6: Parameters used for evaluation of interaction energy 
(Details regarding the estimation of parameters have been shown in S7 of ESI) 
Physical parameter Value 
Hamaker Constant (A)28 
 
7 × 10-21J 
 
Radius of an erythrocyte (a) Healthy = 2.78 ×10-6 m 
Carrier = 2.56×10-6 m 
 
Number of cells in one layer (n) Healthy=137931 
Carrier=126984 
Surface potential of cells Healthy= -12mV 
Carrier= -9mV 
Surface potential of substrate (glass) -60mv 
Reciprocal of Debye Huckel length 
( )
28 
 
(0.78)-1 (nm)-1 
 
Total number of stacks in the hexagonal 
close packed arrangement of cells (NStack) 
Healthy = 58 
Carrier = 63 
Base diameter of the droplet (r) 1.3×10-3 m 
Height of a single layer of cells Healthy = 5.56×10-6 m 
Carrier= 5.12×10-6 m 
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The total interaction energy can be evaluated upon summing the respective van der Waals 
and electric double layer energy components for cell-substrate and cell-cell interactions. 
Total Interaction Energy = _VDW CSU + _EDL CSU + _VDW CCU + _EDL CCU ……… (6) 
The interaction energies thus evaluated have been shown in Figure 8.  
 
Figure 8: Variation of the total interaction energies of the healthy and the carrier samples as a function of cell-to-
substrate distance 
It has been discerned that the total interaction energy of the system consisting of healthy cells 
was distinctly higher in magnitude as compared to the carriers. This increase in the interaction 
energy was, hence, manifested in the form of longer cracks in the healthy samples as compared 
to the carriers. A direct implication of the increase in the interaction energy also resulted in early 
initiation of cracks in the healthy samples (as shown in Figures S8 and S9 of ESI).  
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4.  CONCLUSION 
The present study has conclusively proved that distinct patterns are observed on drying of whole 
blood droplets for carrier and normal samples.  Length of the radial cracks is significantly shorter 
for carrier samples as compared to normal ones. This difference in the crack lengths of the dried 
blood droplet patterns in the healthy and the carrier samples has been explained in terms of the 
total interaction energy of the system, comprising the cell-substrate and the cell-cell interactions. 
Higher magnitude of the total interaction energy resulted in the formation of the longer cracks in 
the healthy samples as compared to the carriers. The in-house developed program, ASAP, 
automatically classified the samples as healthy or carriers based on their crack lengths. It 
categorized a sample as a carrier whose average crack length was less than 800 microns, whereas 
the ones with larger radial cracks were classified as normal. To use this technique as an on field 
method, these patterns can be further utilized to create a databank for automated classification of 
the samples, by employing appropriate techniques from computational pattern recognition and 
deep learning. Proposed method will examine the images of dried blood drops, extract its 
distinctive features and categorize as normal or carrier samples by comparing it with reference 
images stored in the databank. This automated process will remarkably increase the number of 
total population screened for thalassaemia per year in the country and will reduce the burden in 
the state run advanced health facilities along with a significant reduction in costs incurred for 
screening of each sample. 
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SUPPORTING INFORMATION 
 
S1. 
 
 
28 | P a g e  
 
Figure S1: Dried blood drop patterns of carrier samples (the numbers on the top left denote the serial numbers 
whereas the ones below denote the average crack lengths) 
S2. 
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Figure S2: Dried blood drop patterns of healthy samples (the numbers on the top left denote the serial numbers 
whereas the ones below denote the average crack lengths) 
S3. Table S3: Classification of carrier samples by both analyzing the crack lengths and the clinical diagnostic 
method 
SL.No Age Sex Diagnosis HPLC 
Test 
No. 
HB MCV MCH HBA0 HBA2 HBF HBA2e Crack 
length 
(in 
microns) 
41 30 Male Beta 
thalassaemia 
carrier 
320 13.1 64.8 20 85.2 5.7 0.8  646 
 
42 37 Male Beta 
thalassaemia 
carrier 
340 12.7 68 20.9 83.9 5.2 0.4  697 
 
43 20 Male HbE carrier 354 13.3 74.2 24.2 59.5  0.8 30.4 667 
 
44 27 Male Beta 
thalassaemia 
368 12 63.8 18.8 85.9 5.4 0.3  601 
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carrier 
45 31 Male Beta 
thalassaemia 
carrier 
526 13.6 63.9 19.2 85.7 5.1 0.4  722 
 
46 20 Female HbE carrier 533 9.6 75.2 22.1 66.4  0.8 25.5 475 
 
47 26 Male Beta 
thalassaemia 
carrier 
548 13.4 67 20.4 85.1 5.1 0.3  750 
 
48 32 Female HbE carrier 572 9.9 73.1 23.6 64.2  0.6 27.1 670 
 
49 25 Female HbE carrier 2 12.1 76.2 25.9 63.8  0.5 26.3 584 
 
50 34 Male Beta 
thalassaemia 
carrier 
14 11.8 64.8 20.1 79.5 5 0.8  764 
 
51 28 Female HbE carrier 28 11.1 80.7 26.2 61.8  0.3 21.3 644 
 
52 15 Female Beta 
thalassaemia 
carrier 
32 10.9 82.4 25.2 86.6 5 0.2  712 
 
53 25 Female HbE carrier 44 11.3 82.6 28 56.9  0.3 25.5 674 
 
54 30 Male HbE carrier 53 14.4 79.2 26.8 63.6  0.7 25.5 744 
 
55 24 Female HbE carrier 59 11.3 76.4 24.9 64.7  0.6 24.4 649 
 
56 24 Male Beta 
thalassaemia 
carrier 
75 14 69.4 21.3 85 4.8 0.4  759 
 
57 20 Female HbE carrier 82 11.6 80.2 27 65.4  0.8 24.4 672 
 
58 23 Female Beta 
thalassaemia 
carrier 
102 8.3 69.1 21.4 86.3 4.6 0.7  591 
 
59 19 Female HbE carrier 135 9.8 78.5 25.7 68.3  0.6 25.1 611 
 
60 24 Female HbE carrier 147 11.2 75.9 24.8 66  0.8 25.5 779 
 
61 26 Male HbE carrier 165 13.5 76.4 24.9 65.2  0.5 27.4 735 
 
62 19 Female HbE carrier 172 11.4 74.2 25.4 66  0.6 27.3 738 
 
63 24 Male HbE carrier 175 13.8 73.8 24.9 66  0.9 26.4 651 
 
64 16 Female Beta 
thalassaemia 
carrier 
28 11 75.6 22.4  5.3 0.5  741 
 
65 18 Male Beta 
thalassaemia 
carrier 
44 12 67.1 19.7  5.4 0.2  619 
 
66 16 Female Beta 
thalassaemia 
carrier 
61 7.7 61.9 17.7  5.2 0.3  665 
 
67 16 Female Beta 
thalassaemia 
carrier 
13 11 75.3 22.7  4.7 0.4  612 
 
68 18 Female Beta 
thalassaemia 
carrier 
47 11 77.6 23.2  5.4 1.1  588 
 
69 12 Male Beta 
thalassaemia 
carrier 
89 11 69 1.2  5.3 0.2  581 
 
70 24 Male HbE carrier 124 11.9 76.5 25.2 64.2  0.7 28 595 
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S4. Table S4: Classification of healthy samples by both analyzing the crack lengths and the clinical diagnostic 
method 
Sl .No Sex HPLC Test 
NO. 
HB MCV MCH HBA2 HBF Crack 
Length (in 
microns) 
71 Male 70 15 79 26 3 0.2 971 
 
72 Male 84 12 86.3 27.1 3.3 0.2 883 
 
73 Male 72 12 70.8 21.9 2.8 0.2 900 
 
74 Female 64 11 73 22.4 3 0.2 906 
 
75 Male 57 12 75.5 23.3 3.3 0.3 973 
 
76 Male 74 15 82.6 26.4 2.8 0.2 1003 
 
77 Male 73 14 74.1 22.7 2.9 0.1 964 
 
78 Female 7 11.1 82.5 25.3 2.6 0.2 908 
79 Male 22 12 77.8 23.8 2.6 0.2 886 
80 Male 56 12 76.1 23.3 3 0.1 908 
 
81 Male 87 13 70.1 21.9 2.5 0.2 811 
 
82 Male 17 12 85.3 25.5 2.5 0.2 849 
 
83 Male 19 13 78.7 23.7 2.7 0.2 940 
84 Male 93 12 67.1 19.9 3 0.3 906 
 
85 Male 60 13 68.3 20.8 2.9 0.2 875 
 
86 Female 100 11 69.6 21.7 2.9 0.1 883 
 
87 Female 66 12 72.3 21.7 3 0.3 938 
 
88 Female 36 11 72.2 20.9 2.9 0.3 948 
89 Male 58 12 67.1 20.6 3.2 0.2 853 
 
90 Female 63 12 81.7 26.5 3 0.3 978 
 
91 Male 1 12.7 84.1 25.8 2.4 0.1 852 
92 Male 55 12 69.1 21.1 3.3 0.7 964 
 
93 Female 65 9.5 64.8 17.9 2.8 0.2 887 
 
94 Male 25 14 72.3 21.1 2.8 0.4 944 
95 Female 99 12 70.1 21.1 2.9 0.2 1186 
 
96 Male 3 13.7 72.9 21.7 2.8 0.3 1351 
97 Female 54 13 84.1 27.2 2.8 0.2 1007 
 
98 Male 76 13 85.5 27.9 3.3 0.4 982 
 
99 Male 29 13 76.4 23.4 2.6 0.2 986 
100 Male 52 14 82.8 25.7 2.6 0.2 888 
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S5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5: Drop drying pattern of whole blood (4 l) on glass substrates [(a) & (b) carrier samples; (c) & (d) 
healthy samples ] 
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S6. Table S6: Comparison of the crack lengths as estimated by ImageJ and ASAP 
SL.NO Crack length as estimated by 
ImageJ 
(m) 
Crack length as detected by 
ASAP 
(m) 
Category 
41 646 
 
620 Carrier 
42 697 
 
756 Carrier 
43 667 
 
712 Carrier 
44 601 
 
642 Carrier 
45 722 
 
760 Carrier 
46 475 
 
62 Carrier 
47 750 
 
754 Carrier 
48 670 
 
667 Carrier 
49 584 
 
715 Carrier 
50 764 
 
777 Carrier 
51 644 
 
703 Carrier 
52 712 
 
708 Carrier 
53 674 
 
744 Carrier 
54 744 
 
722 Carrier 
55 649 
 
607 Carrier 
56 759 
 
773 Carrier 
57 672 
 
722 Carrier 
58 591 
 
619 Carrier 
59 611 
 
665 Carrier 
60 779 
 
707 Carrier 
61 735 
 
739 Carrier 
62 738 
 
752 Carrier 
63 651 
 
776 Carrier 
64 741 
 
703 Carrier 
65 619 
 
638 Carrier 
66 665 
 
779 Carrier 
67 612 
 
740 Carrier 
68 588 
 
618 Carrier 
69 581 
 
618 Carrier 
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70 595 
 
678 Carrier 
71 971 
 
936 Healthy 
72 883 
 
919 Healthy 
73 900 
 
864 Healthy 
74 906 
 
868 Healthy 
75 973 
 
935 Healthy 
76 1003 
 
965 Healthy 
77 964 
 
1006 Healthy 
78 908 866 Healthy 
79 886 844 Healthy 
80 908 
 
864 Healthy 
81 811 
 
856 Healthy 
82 849 
 
802 Healthy 
83 940 892 Healthy 
84 906 
 
957 Healthy 
85 875 
 
823 Healthy 
86 883 
 
830 Healthy 
87 938 
 
874 Healthy 
88 948 928 Healthy 
89 853 
 
781 Healthy 
90 978 
 
903 Healthy 
91 852 927 Healthy 
92 964 
 
887 Healthy 
93 887 
 
809 Healthy 
94 944 863 Healthy 
95 1186 
 
1102 Healthy 
96 1351 1266 Healthy 
97 1007 
 
916 Healthy 
98 982 
 
887 Healthy 
99 986 886 Healthy 
100 888 
 
935 Healthy 
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S7. The height of a dried drop of whole blood was estimated by a surface profilometer (3D non 
contact surface profilometer, Contour- GTK), Bruker) and was found to be ~ 320 microns. The 
image of a dried blood droplet has been shown in Figure S7. 
 
Figure S7: Image of a dried blood droplet 
For healthy samples,  
Total number of stacks in the hexagonal close packed arrangement of cells, NStack  
= (Height of dried blood drop) / (Diameter of each cell) 
= (320 ×10-6)/( 2.78 ×10-6×2) 
 = 58 
Total number of cells in a 2l droplet = 8 ×106 cells  
So, number of cells in a single layer (n∞) = (8 ×10
6/58) = 137931 
Similarly, for carrier samples, NStack = (320 ×10
-6)/( 2.56 ×10-6×2) = 63 
n∞= (8 ×10
6/63) = 126984 
36 | P a g e  
 
S8. 
 
Figure S8: Crack formation in a carrier sample 
S9. 
 
Figure S8: Crack formation in a healthy sample 
